These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31594451)

  • 1. Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes.
    Yap DYH; Thong KM; Yung S; Tang C; Ma BMY; Chan TM
    Lupus; 2019 Oct; 28(12):1460-1467. PubMed ID: 31594451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antiphospholipid antibodies with clinical activity and renal pathological activity in patients with lupus nephritis.
    Zhang J; Zhang J; Zhou Q; Lu G; You X
    Lupus; 2021 Jun; 30(7):1140-1145. PubMed ID: 33832360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.
    Moroni G; Ventura D; Riva P; Panzeri P; Quaglini S; Banfi G; Simonini P; Bader R; Meroni PL; Ponticelli C
    Am J Kidney Dis; 2004 Jan; 43(1):28-36. PubMed ID: 14712424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases.
    Zheng H; Chen Y; Ao W; Shen Y; Chen XW; Dai M; Wang XD; Yan YC; Yang CD
    Arthritis Res Ther; 2009; 11(3):R93. PubMed ID: 19545416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.
    Pengo V; Ruffatti A; Del Ross T; Tonello M; Cuffaro S; Hoxha A; Banzato A; Bison E; Denas G; Bracco A; Padayattil Jose S
    J Thromb Haemost; 2013 Aug; 11(8):1527-31. PubMed ID: 23601766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
    Pengo V; Ruffatti A; Legnani C; Gresele P; Barcellona D; Erba N; Testa S; Marongiu F; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    J Thromb Haemost; 2010 Feb; 8(2):237-42. PubMed ID: 19874470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis.
    Tsuruta Y; Uchida K; Itabashi M; Yumura W; Nitta K
    Intern Med; 2009; 48(21):1875-80. PubMed ID: 19881237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis.
    Fofi C; Cuadrado MJ; Godfrey T; Abbs I; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 2001; 19(1):75-7. PubMed ID: 11247329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
    Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
    Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
    Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
    Front Immunol; 2018; 9():2457. PubMed ID: 30464761
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients.
    Pandya J; Onel K; Erkan D
    Pediatr Rheumatol Online J; 2024 Apr; 22(1):46. PubMed ID: 38671480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study.
    Abisror N; Nguyen Y; Marozio L; Esteve Valverde E; Udry S; Pleguezuelo DE; Billoir P; Mayer-Pickel K; Urbanski G; Zigon P; De Moreuil C; Hoxha A; Bezanahary H; Carbillon L; Kayem G; Bornes M; Yelnik C; Johanet C; Nicaise-Roland P; Lambert M; Salle V; Latino OJ; Hachulla E; Benedetto C; Bourrienne MC; Benhamou Y; Alijotas-Reig J; Fain O; Mekinian A;
    RMD Open; 2020 Aug; 6(2):0. PubMed ID: 32848089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
    Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
    Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.